A detailed history of Ifm Investors Pty LTD transactions in Boston Scientific Corp stock. As of the latest transaction made, Ifm Investors Pty LTD holds 309,327 shares of BSX stock, worth $28.2 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
309,327
Previous 307,730 0.52%
Holding current value
$28.2 Million
Previous $23.7 Million 9.38%
% of portfolio
0.25%
Previous 0.24%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$72.96 - $84.0 $116,517 - $134,148
1,597 Added 0.52%
309,327 $25.9 Million
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $244,205 - $281,854
3,627 Added 1.19%
307,730 $23.7 Million
Q1 2024

Apr 22, 2024

SELL
$57.6 - $68.62 $302,227 - $360,049
-5,247 Reduced 1.7%
304,103 $20.8 Million
Q4 2023

Jan 12, 2024

BUY
$48.64 - $57.81 $716,418 - $851,483
14,729 Added 5.0%
309,350 $17.9 Million
Q3 2023

Oct 26, 2023

BUY
$50.19 - $54.68 $429,827 - $468,279
8,564 Added 2.99%
294,621 $15.6 Million
Q2 2023

Jul 27, 2023

BUY
$49.72 - $54.64 $1 Million - $1.1 Million
20,169 Added 7.59%
286,057 $15.5 Million
Q1 2023

May 11, 2023

BUY
$45.09 - $50.03 $292,859 - $324,944
6,495 Added 2.5%
265,888 $13.3 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $195,624 - $233,502
4,945 Added 1.94%
259,393 $12 Million
Q3 2022

Oct 12, 2022

BUY
$36.71 - $109.66 $136,928 - $409,031
3,730 Added 1.49%
254,448 $9.86 Million
Q2 2022

Jul 15, 2022

BUY
$35.24 - $47.1 $327,344 - $437,511
9,289 Added 3.85%
250,718 $9.34 Million
Q1 2022

Apr 13, 2022

BUY
$40.9 - $45.1 $1.79 Million - $1.97 Million
43,729 Added 22.12%
241,429 $10.7 Million
Q4 2021

Jan 18, 2022

BUY
$38.07 - $44.87 $182,736 - $215,376
4,800 Added 2.49%
197,700 $8.4 Million
Q3 2021

Oct 13, 2021

BUY
$41.23 - $45.88 $125,009 - $139,108
3,032 Added 1.6%
192,900 $8.37 Million
Q2 2021

Jul 16, 2021

BUY
$38.58 - $44.24 $1.11 Million - $1.28 Million
28,829 Added 17.9%
189,868 $8.12 Million
Q1 2021

May 05, 2021

BUY
$35.27 - $39.67 $779,854 - $877,143
22,111 Added 15.92%
161,039 $6.22 Million
Q4 2020

Jan 13, 2021

BUY
$33.15 - $41.97 $705,034 - $892,617
21,268 Added 18.08%
138,928 $4.99 Million
Q3 2020

Oct 16, 2020

BUY
$34.44 - $42.23 $497,864 - $610,476
14,456 Added 14.01%
117,660 $4.5 Million
Q2 2020

Jul 13, 2020

SELL
$30.19 - $39.11 $1.05 Million - $1.37 Million
-34,915 Reduced 25.28%
103,204 $3.62 Million
Q1 2020

Apr 09, 2020

SELL
$25.83 - $45.71 $130,828 - $231,521
-5,065 Reduced 3.54%
138,119 $4.37 Million
Q4 2019

Jan 13, 2020

SELL
$37.87 - $45.37 $256,872 - $307,744
-6,783 Reduced 4.52%
143,184 $6.48 Million
Q3 2019

Nov 01, 2019

BUY
$40.31 - $43.45 $2.15 Million - $2.31 Million
53,258 Added 55.07%
149,967 $6.1 Million
Q2 2019

Jul 16, 2019

BUY
$34.91 - $42.98 $234,036 - $288,137
6,704 Added 7.45%
96,709 $4.16 Million
Q1 2019

Apr 18, 2019

BUY
$32.91 - $40.75 $338,183 - $418,747
10,276 Added 12.89%
90,005 $3.45 Million
Q4 2018

Jan 23, 2019

BUY
$31.73 - $39.04 $227,345 - $279,721
7,165 Added 9.87%
79,729 $2.82 Million
Q3 2018

Oct 22, 2018

BUY
$32.83 - $38.63 $336,802 - $396,305
10,259 Added 16.47%
72,564 $2.79 Million
Q2 2018

Jul 09, 2018

BUY
$26.84 - $34.32 $507,759 - $649,265
18,918 Added 43.6%
62,305 $2.04 Million
Q1 2018

May 11, 2018

BUY
$25.2 - $28.54 $104,554 - $118,412
4,149 Added 10.57%
43,387 $1.19 Million
Q4 2017

Jan 29, 2018

BUY
$24.79 - $29.8 $3,644 - $4,380
147 Added 0.38%
39,238 $973,000
Q3 2017

Nov 16, 2017

BUY
$26.26 - $29.17 $53,517 - $59,448
2,038 Added 5.5%
39,091 $1.14 Million
Q2 2017

Aug 10, 2017

BUY
N/A
9,538 Added 34.66%
37,053 $1.03 Million
Q1 2017

Aug 17, 2017

BUY
N/A
27,515
27,515 $684,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ifm Investors Pty LTD Portfolio

Follow Ifm Investors Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.